Surgery – Controlled release therapeutic device or system
Patent
1994-02-01
1996-09-10
Rosenbaum, C. Fred
Surgery
Controlled release therapeutic device or system
604265, 6048911, 424423, A61K 922
Patent
active
055541470
ABSTRACT:
A method for the controlled release of a biologically active agent wherein the agent is released from a hydrophobic, pH-sensitive polymer matrix is disclosed and claimed. The polymer matrix swells when the environment reaches pH 8.5, releasing the active agent. A polymer of hydrophobic and weakly acidic comonomers is disclosed for use in the controlled release system. Further disclosed is a specific embodiment in which the controlled release system may be used. The pH-sensitive polymer is coated onto a latex catheter used in ureteral catheterization. A common problem with catheterized patients is the infection of the urinary tract with urease-producing bacteria. In addition to the irritation caused by the presence of the bacteria, urease produced by these bacteria degrade urea in the urine, forming carbon dioxide and ammonia. The ammonia causes an increase in the pH of the urine. Minerals in the urine begin to precipitate at this high pH, forming encrustations which complicate the functioning of the catheter. A ureteral catheter coated with a pH-sensitive polymer having an antibiotic or urease inhibitor trapped within its matrix will release the active agent when exposed to the high pH urine as the polymer gel swells. Such release can be made slow enough so that the drug remains at significant levels for a clinically useful period of time.
REFERENCES:
patent: 3067745 (1962-12-01), Burgeni
patent: 3861396 (1975-01-01), Vaillancourt
patent: 4743248 (1988-05-01), Barton et al.
patent: 4999210 (1991-03-01), Solomon et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5152758 (1992-10-01), Kaetsu et al.
patent: 5165952 (1992-11-01), Solomon et al.
patent: 5217493 (1993-06-01), Raad et al.
patent: 5261896 (1993-11-01), Conway et al.
The Merck Index, 10th edition, 1983, pp. 946-947.
Brazzini, A. et al. (1987) "Urostent Designs" Seminars in Interventional Radiology 4(1):26-34.
Reid, G. et al. (1993) "Adsorption of ciprofloxacin to urinary catheters and effect on subsequent bacterial adhesion and survival" Colloids and Surfaces B:Biointerfaces 1:9-16.
Ritger, P. L., N. A. Peppas (1987) "A Simple Equation for Decsription of Solute Release II. Fickian and Anomalous Release from Swellable Devices" Journal of Controlled Release 5:37-42.
Solomon, D. D., R. J. Sherertz (1987) "Antibiotic Releasing Polymers" Journal of Controlled Release 6:343-352.
Korsmeyer, R. W., N. A. Peppas (1984) "Solute and Penetrant Diffusion in Swellable Polymers. III. Drug Release from Glassy Poly (HEMA-co-NVP) Copolymers" Journal of Controlled Release 1:89-98.
Brannon-Pappas, L., N. A. Pappas (1989) "Solute and Penetrant Diffusion in Swellable Polymers. IX. The Mechanisms of Drug Release from ph-Sensitive Swelling-Controlled Systems" Journal of Controlled Release 8:267-274.
Franco, G. et al. (1990) "The Incidence of Post-operative Urinary Tract Infection in Patients with Ureteric Stents" British Journal of Urology 65:10-12.
Stamm, W. E. (1991) "Catheter-Associated Urinary Tract Infections: Epidemiology, Pathogenesis, and Prevention" The American Journal of Medicine 91 (suppl 3B):65S-71S.
Nickel, J. C., et al. (1992) "Movement of Pseudomonas Aeruginosa Along Catheter Surfaces" Urology 39(1):93-98.
Swartz, R. et al. (1991) "Biofilm Formation on Peritoneal Catheters Does Not Require the Presence of Infection" Trans. Am. Soc. Artif. Intern. Organs 37:626-634.
McLean R. J. C. et al. (1991) "Pyrophosphate inhibition of Proteus mirabilis-induced struvite crystallization in vitro" Clinica Chimica Acta. 200:107-118.
Olson, M. E. et al. (1989) "Animal Model of Human Disease" American Journal of Pathology 135(3):581-583.
McLean, R. J. C. et al. (1990) "Influence of Chondroitin Sulfate, Heparin Sulfate, and Citrate on Proteus Mirabilis-Induced Struvite Crystallization In Vitro" The Journal of Urology 144(1267-1271.
Liedberg, H. et al. (1990) "Refinements in the Coating of Urethral Catheters Reduces the Incidence of Catheter-Associated Bacteriuria" Eur. Urol. 17:236-240.
Breitenbach, J. M., R. P. Hausinger (1988) "Proteus mirabilis urease" Biochem. J. 250:917-920.
Takeuchi, H. et al. (1980) "Prevention of Infected Urinary Stones in Rats by Urease Inhibitor" Investigative Urology 18;102-105.
Pearce, R. S. C. et al. (1984) "Evaluation of a New Hydrogel Coating for Drainage Tubes" The American Journal of Surgery 148:687-691.
Ramsay, J. W. A. et al. (1986) "An Experimental Study of Hydrophilic Plastics for Urological Use" British Journal of Urology 58:70-74.
Mardis, H. K., R. M. Kroeger (1988) "Ureteral Stents" Urologic Clinics of North America 15(3):471-479.
Batich Christopher D.
Cohen Marc S.
Foster Kirk
CApHCO, Inc.
Rosenbaum C. Fred
Smith Chalin
LandOfFree
Compositions and devices for controlled release of active ingred does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and devices for controlled release of active ingred, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and devices for controlled release of active ingred will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1317290